Tony Wang, MD
Radiation Oncology · New York, NYNPI 1265682819
Payments from drug & device makers
What this record shows
This record is dominated by speaking fees: $6,100 of the $7,635 with a category attached, or 79.9%. Novocure Inc. accounts for 63.9% of it on its own, with 4 other manufacturers making up the rest. Reporting peaked in 2019 at $6,379 and has fallen 96.4% since, to $227 in 2025.
Across 15 payments — averaging $509.02 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Novocure Inc.$5K
- Elekta, Inc.$2K
- Elekta Instrument AB$1K
- Balt USA, LLC$227
- Phenox Inc.$30
Across 3 payments — averaging $87,000 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Siemens Medical Solutions USA, Inc.$261K
What the payments were for
- Speaking & faculty fees$6,10080%
- Travel & lodging$1,05314%
- Food & beverage$4836%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Novocure Inc. | 11 | $4,879 |
| Elekta, Inc. | 1 | $1,500 |
| Elekta Instrument AB | 1 | $1,000 |
| Balt USA, LLC | 1 | $227 |
| Phenox Inc. | 1 | $30 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Oncology$4,573
- Icon$1,500
- Perfection$1,500
- LEKSELL GAMMA KNIFE ICON$1,000
- LEKSELL GAMMA KNIFE PERFEXION$1,000
- LEKSELL GAMMAPLAN$1,000
- Leksell Stereotactic System$1,000
- LEKSELL VANTAGE STEREOTACTIC SYSTEM$1,000
- Raptor Aspiration Catheter$227
How this compares
$7,635 in reported general payments places this provider in the 85th percentile of 397 radiation oncology providers in New York.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Other radiation oncology in New York
- Michael ZelefskyNew York$946K
- Nancy LeeNew York$233K
- Robert SamsteinNew York$125K
- Jalal AhmedNew York$100K
- Charles SimoneNew York$84K
- Silvia FormentiNew York$57K
- Brandon ImberNew York$44K
- Himanshu NagarNew York$43K
- Chiaojung TsaiNew York$38K
- Christopher BarkerNew York$32K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.